Related Experiment Video
Updated: Apr 3, 2026

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
In this issue of Blood, Donadieu et al present what may be the most encouraging data to date on a group of patients with Langerhans cell histiocytosis (LCH), which historically has poor disease-free survival and poor overall survival.
In this issue of Blood, Donadieu et al present what may be the most encouraging data to date on a group of patients with Langerhans cell histiocytosis (LCH), which historically has poor disease-free survival and poor overall survival.
Related Concept Videos
Relative Risk
Hazard Ratio
For example, in a clinical trial...
Drug Toxicity: Risk factors
Hazard Rate
Coronary Artery Disease IV: Preventive Measures
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

